For decades, London has been one of the most recognisable destinations in the world for international private healthcare patients, particularly from the Gulf region. The city’s hospitals have become synonymous with high quality advanced oncology, complex cardiac work, and specialist diagnostics, and an entire ecosystem has grown around this flow of travellers. Following on from our column last week which looked at Gulf investment in luxury fashion, this week we are turning our attention towards the major investment and expanding clinical capabilities which are appearing across the Middle East, and adding new momentum to the international flow of patients.
Healthcare in the Middle East – once viewed as an area best outsourced to international centres – has become a strategic national priority. Governments are investing heavily in infrastructure, training, research and digital capability, to serve their own population’s healthcare needs, to diversify and strengthen economies, and to attract healthcare tourists. Saudi Arabia’s Vision 2030 created a blueprint for medical cities that integrate treatment with education and innovation, while Dubai has positioned itself as a global hub for medical tourism, aiming to attract 1.3 million international patients each year with a blend of clinical excellence and hospitality.
Kuwait offers one of the clearest illustrations of this wider change. A decade ago, the country approved more than 9,000 overseas treatment cases each year and the UK, US and Germany received about 75% of all those referrals. Now, annual approvals sit closer to 4,500, and the cases that do go abroad are both more selective and more widely distributed, but also increasingly complex.
“Saudi Arabia’s Vision 2030 created a blueprint for medical cities that integrate treatment with education and innovation, while Dubai has positioned itself as a global hub for medical tourism.”
Across the Middle East, the momentum behind healthcare investment is now visible in day-to-day practice. Cleveland Clinic Abu Dhabi has surpassed six million patient encounters, King’s College Hospital Dubai has broadened its specialist services, and Mayo Clinic-affiliated centres in Saudi Arabia are delivering increasingly complex care. These advances are helping to build a more connected, specialist, system, with stronger links between centres and clearer routes for patients and clinicians alike.
Yet, in parallel with this momentum, London continues to thrive, holding its place in a global healthcare landscape that is becoming more connected and more ambitious. As Abi Stapleton, Chief Commercial Officer at Cleveland Clinic London, describes: “London has always been an international hub, so we still see many patients from a range of different geographies. Although they may not be coming from embassy-sponsored care as much as before Covid, these patients are still a core part of the London market, which is still growing, with both domestic and international patients”. Abi attributes that growth to the depth of expertise that continues to draw people to the city. “London is a hub for complex care”, she explains, noting that many of the patients who arrive today have “more intricate needs”, and sometimes multiple conditions, that require a multidisciplinary approach.
The quality of service, as well as speciality care, is critical here. Cleveland Clinic are increasingly offering their patients seamless global care, with early consultations in one home market and then specialist treatment in another. Julia Hendrickson, CEO of The Private Clinic Group, meanwhile describes developing bespoke packages of treatment and care for individual patients, offering recovery in boutique hotels, personalised nutrition support, and seamless travel alongside the reputation of The Private Clinic Group’s world-leading clinicians in bringing patients to their doors, often through word-of-mouth referral.
This highlights another avenue in which London is rapidly emerging as a global centre: preventative healthcare. Abi tells me she is seeing “an increasing number of people interested in longevity and wellness”, while Julia says that The Private Clinic Group, which is one such business which develops evidence-based propositions around longevity and support, is able to nurture increasingly long-standing relationships with patients, which in turn, is leading to a growing international customer base.
Changes in who is travelling, and why, also reflect a broader pattern in how people choose to access care. Many Middle Eastern patients who once arrived through embassy channels now come independently, often because London is already part of their lives and social networks. Abi explains: “People may have properties or businesses in London, and healthcare then becomes part of that journey.” That widening mix of influences is also attracting attention from across the Atlantic, where US operators are investing heavily in London’s private healthcare sector. A recent Candesic and Barclays report notes that six major US organisations now account for nearly half of the city’s private hospital supply, drawn by strong demand, reputation, and London’s role as an international gateway. Their arrival brings new models, new capital and a wider network of global relationships into the market.
Nowhere is this more evident than in South Africa. The country has long attracted international patients from across the continent, the Gulf and further afield, supported by strong clinical training, competitive pricing and a reputation for high-quality care. But the rapid rise of facilities in Riyadh, Dubai and Abu Dhabi, and Qatar is beginning to influence those pathways.
For patients travelling from East Africa, the Gulf now offers shorter journeys, purpose-built medical districts and an experience that blends clinical treatment with the kind of hospitality the region is known for. At the same time, affluent Middle Eastern patients who once looked to Cape Town or Johannesburg for elective procedures are increasingly choosing centres closer to home, drawn by the luxury environment and specialist expertise now available domestically. The result is a gradual change in flow: South Africa is still a key destination for cross-border care within Africa, though its link with the Gulf is adjusting as leading facilities grow in the region.
“The market will continue to grow, the prevention agenda will become more important, and we’ll see more specialist and innovative care happening in the private sector.” – Abi Stapleton, Chief Commercial Officer, Cleveland Clinic London
The same dynamic is shaping developments more widely across the continent. Across Africa, large-scale projects are gathering momentum, from South Africa’s well-established private sector to new ventures like King’s College Hospital’s partnership in Nigeria. The Gulf’s trajectory from importer to innovator is now being mirrored, at varying speeds, in other regions seeking to strengthen their domestic healthcare capabilities.
London, though, remains a consistent and growing presence in this landscape, shaped by the expertise of its clinicians and the strength of its specialist services. Hospitals across the city are now working more closely with counterparts abroad, supporting patients whose treatment may unfold across different regions. It is a pattern Abi recognises. “The market will continue to grow as prevention becomes more important, and we’ll see more specialist and innovative care happening in the private sector,” she tells me, pointing to a trajectory that plays naturally to London’s capabilities.
The rapid expansion of healthcare across the Gulf is adding real depth to the global healthcare system, with Riyadh, Dubai, Abu Dhabi and Kuwait City becoming meaningful points of connection. As capability builds, patients are increasingly able to draw on care in more than one location, and London’s role within that picture remains dynamic and innovative, shaped by the expertise that has long defined it. The momentum now running through these Middle Eastern hubs is setting a new pace for international medicine, and new standards around quality of care, and its influence is likely to shape the sector for years to come.
